WHO and USFDA views on repurposed meds start a debate

The World Health Organisation (WHO) and the US Food and Drug Administration (USFDA) have taken opposite stands on repurposed medicines (drugs used for treatment other than the intended) for COVID-19. Recently, remdesivir was approved by the USFDA to treat COVID-19 patients, while the WHO had said it had little or no effect on...